Edap Tms (NASDAQ:EDAP) Raised to Hold at StockNews.com

StockNews.com upgraded shares of Edap Tms (NASDAQ:EDAP) from a sell rating to a hold rating in a report released on Wednesday.

Separately, HC Wainwright restated a buy rating and issued a $19.00 target price on shares of Edap Tms in a report on Thursday, August 29th.

Edap Tms Trading Down 2.1 %

NASDAQ EDAP opened at $2.81 on Wednesday. The firm has a market capitalization of $104.26 million, a PE ratio of -5.20 and a beta of 0.43. The business’s 50-day moving average price is $3.84 and its two-hundred day moving average price is $5.52. The company has a current ratio of 2.45, a quick ratio of 1.80 and a debt-to-equity ratio of 0.03. Edap Tms has a 12 month low of $2.71 and a 12 month high of $8.50.

Edap Tms (NASDAQ:EDAP) last announced its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.04). Edap Tms had a negative net margin of 31.68% and a negative return on equity of 36.41%. The company had revenue of $16.97 million during the quarter, compared to the consensus estimate of $17.16 million. On average, analysts expect that Edap Tms will post -0.59 EPS for the current year.

Institutional Investors Weigh In On Edap Tms

A number of hedge funds have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new stake in shares of Edap Tms during the 1st quarter worth approximately $82,000. Miracle Mile Advisors LLC acquired a new stake in Edap Tms in the first quarter worth $136,000. Roubaix Capital LLC acquired a new stake in Edap Tms in the first quarter worth $169,000. Finally, Commonwealth Equity Services LLC increased its stake in Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after purchasing an additional 4,000 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.